| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 28 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.90M | - | |
| COO | 160.7K | $8.38M | - | |
| CFO | 104.4K | $5.44M | - | |
| Other | 76.0K | $3.96M | - | |
| VP | 29.0K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2021 | Wright-Mitchell Jane65 | General Counsel | Sale+OE | 2,500 | $26.00 | $65,000.00 | -61.5% | |
| Jan 13, 2021 | Hopfner Robert Lorne | Director | Sell | 97,343 | $26.29 | $2,558,948.07 | -0.7% | |
| Jan 11, 2021 | Sauer Paul | SVP Process Dev, Manufacturing | Sale+OE | 2,500 | $26.21 | $65,526.72 | -1.6% | |
| Jan 8, 2021 | Hopfner Robert Lorne | Director | Sell | 145,612 | $28.30 | $4,120,276.60 | -0.9% | |
| Dec 21, 2020 | Pickering Grant50 | President &CEO | Sale+OE | 15,000 | $28.88 | $433,141.04 | -0.9% | |
| Dec 15, 2020 | Tpg Group Holdings (sbs) Advisors, Inc.86 | Former 10% Owner | Sell | 81,979 | $32.50 | $2,664,691.05 | -0.8% | |
| Oct 8, 2020 | Ra Capital Management, L.P.53 | 10% Owner | Sell | 266,258 | $50.78 | $13,521,592.46 | -2.6% | |
| Oct 1, 2020 | Ra Capital Management, L.P.53 | 10% Owner | Sell | 221,330 | $50.81 | $11,245,562.88 | -2.0% | |
| Jun 16, 2020 | Tpg Group Holdings (sbs) Advisors, Inc.86 | 10% Owner | Buy | 937,500 | $16.00 | $15,000,000.00 | +22.2% | |
| Jun 16, 2020 | Heron Patrick J87 | Director | Buy | 250,000 | $16.00 | $4,000,000.00 | +12.1% |